Remove Medical Evaluation Remove Patients Remove Presentation
article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

Fernando Fandio-Sende, LifeCannMD After thirty years practicing medicine and specializing as a Miami cannabis doctor , I’ve had countless conversations with patients who tell me the same thing: “Doctor, I want to try medical marijuana , but I’m scared of getting too high.”

article thumbnail

Telemedicine and MMJ: How Online Consultations Work

MMJ Recs

Telemedicine has transformed healthcare by enabling patients to remotely consult with healthcare professionals. The advantages of telemedicine include improved access to healthcare, convenience for patients, and reduced costs. This discretion encourages more open and honest communication between patients and healthcare providers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

California’s New Cannabis Laws Affect College-Aged Students

Meadow

In addition, young patients could also expose themselves to high levels of pesticides when smoking illegally obtained cannabis. The next steps for patients looking to obtain medical cannabis… Determine if medical cannabis may be a treatment option for you. Welcome back Dr. Dan. Dr. Dan: Thank you. People that are 18+.

Law
article thumbnail

Further Consideration of the STATES Act

Cannabis Law Report

The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). At the present time, state medical and recreational legalization have no impact on federal drug control laws. 3032 and H.R.

article thumbnail

DEA Pushes Marijuana Rescheduling Hearing To December: What Does This Mean For Cannabis?

Veriheal

This shift in federal drug policy would allow cannabis-derived drugs to be legally available by prescription, making the drug more accessible to patients and medical researchers. In August 2023, the HHS also crucially recommended to the DEA that cannabis be relisted from Schedule I to Schedule III.

DEA